#USA #Grand Rapids #Packaging Compliance #Instron #Pharma Lab

Packaging Compliance Labs Enhances Pharma Testing Infrastructure

Overview
Packaging Compliance Labs (PCL) has made a significant capital investment aimed at enhancing its pharmaceutical testing capabilities. Located in Grand Rapids, Michigan, PCL is responding to an increasing demand from life sciences companies. With the installation of three state-of-the-art Instron Universal Testing Systems, the firm aims to bolster its testing and engineering services tailored for pharmaceutical packaging and drug delivery systems.

Investment Rationale
The decision to invest in advanced testing systems stems from the growing need for robust testing protocols in the pharmaceutical sector. With new therapies constantly being developed, life sciences firms are looking for reliable partners to help them bring their products to market efficiently. Matt Lapham, CEO of PCL, highlights, "Our clients have asked us to expand upon our core services and provide further support for pharmaceutical projects." This investment underscores PCL's commitment to assist its clients in overcoming the technical challenges associated with drug delivery.

Features of the New Testing Equipment
The newly acquired Instron Model 6800 Series platforms are instrumental for conducting a variety of ISO 11040 series tests, specifically designed for prefilled syringes. Additionally, the new technologies will facilitate testing of autoinjectors and sterile hypodermic needles. These systems are vital for ensuring that pharmaceutical products can be developed and delivered safely to patients.

The latest generation Autoinjector Testing System has been designed to perform full functionality tests, thereby measuring critical performance outputs of drug delivery devices. This function addresses regulatory standards set forth by entities like ISO 11608, ensuring compliance and quality assurance throughout the testing process.

Market Significance
As the pharmaceutical landscape evolves, particularly with the focus shifting to large molecule therapies, the need for effective device development and performance verification is becoming more crucial. Landon Goldfarb, Life and Tech Segment Manager at Instron, states, “By incorporating the Instron injectable drug delivery testing platform into its new laboratory space, Packaging Compliance Labs is strengthening its ability to evaluate a broad range of drug delivery systems.” This enhancement allows PCL to stay ahead of the curve in an increasingly competitive environment.

The Role of Packaging Compliance Labs
PCL serves as a trusted consulting partner for medical device manufacturers and pharmaceutical companies, offering comprehensive services that encompass testing, engineering, and contract packaging. The organization’s focus on innovation and adherence to regulatory compliance aids clients in navigating the complexities involved in product development and market launch.

Conclusion
As PCL continues to invest in cutting-edge technology and expand its testing capabilities, it positions itself as a leader in the pharmaceutical testing arena. The recent upgrades reflect PCL's dedication to supporting the development of life-saving pharmaceutical products, ensuring that they reach the market quickly and effectively, ultimately benefiting healthcare systems and patients alike.

For more information on Packaging Compliance Labs and its state-of-the-art testing services, visit their official website or contact their team directly.